Germline mutation of the tumour suppressor PTEN in Proteus syndrome.
作者信息
Smith J M, Kirk E P E, Theodosopoulos G, Marshall G M, Walker J, Rogers M, Field M, Brereton J J, Marsh D J
出版信息
J Med Genet. 2002 Dec;39(12):937-40. doi: 10.1136/jmg.39.12.937.
Abstract
摘要
相似文献
1
Germline mutation of the tumour suppressor PTEN in Proteus syndrome.
J Med Genet. 2002 Dec;39(12):937-40. doi: 10.1136/jmg.39.12.937.
2
PTEN mutations are uncommon in Proteus syndrome.
J Med Genet. 2001 Jul;38(7):480-1. doi: 10.1136/jmg.38.7.480.
3
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes.
Lancet. 2001 Jul 21;358(9277):210-1. doi: 10.1016/s0140-6736(01)05412-5.
4
PTEN mutations and proteus syndrome.
Lancet. 2001 Dec 15;358(9298):2079-80. doi: 10.1016/S0140-6736(01)07110-0.
5
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis.
Hum Mol Genet. 2000 Mar 22;9(5):765-8. doi: 10.1093/hmg/9.5.765.
6
Proteus syndrome: misdiagnosis with PTEN mutations.
Am J Med Genet A. 2003 Nov 1;122A(4):323-4. doi: 10.1002/ajmg.a.20474.
7
PTEN: one gene, many syndromes.
Hum Mutat. 2003 Sep;22(3):183-98. doi: 10.1002/humu.10257.
8
Neonatal Proteus syndrome?
Am J Med Genet. 2002 Oct 1;112(2):228-30. doi: 10.1002/ajmg.10650.
9
PTEN mutations and proteus syndrome.
Lancet. 2001 Dec 15;358(9298):2079-80. doi: 10.1016/S0140-6736(01)07109-4.
10
Diagnosis of Proteus syndrome was correct.
Am J Med Genet A. 2004 Oct 1;130A(2):214-5; author reply 216-7. doi: 10.1002/ajmg.a.30337.
引用本文的文献
1
Hamartomatous polyps: Diagnosis, surveillance, and management.
World J Gastroenterol. 2023 Feb 28;29(8):1304-1314. doi: 10.3748/wjg.v29.i8.1304.
2
Immature teratoma in an adolescent with Proteus syndrome: A novel association.
Clin Case Rep. 2021 May 4;9(5):e04143. doi: 10.1002/ccr3.4143. eCollection 2021 May.
3
Characterization and Childhood Tumor Risk Assessment of Genetic and Epigenetic Syndromes Associated With Lateralized Overgrowth.
Front Pediatr. 2020 Dec 17;8:613260. doi: 10.3389/fped.2020.613260. eCollection 2020.
4
Proteus syndrome of the foot: A case report and literature review.
Exp Ther Med. 2020 Sep;20(3):2716-2720. doi: 10.3892/etm.2020.8986. Epub 2020 Jul 10.
5
PTEN in Hereditary and Sporadic Cancer.
Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036087. doi: 10.1101/cshperspect.a036087.
6
PTEN-opathies: from biological insights to evidence-based precision medicine.
J Clin Invest. 2019 Feb 1;129(2):452-464. doi: 10.1172/JCI121277. Epub 2019 Jan 7.
7
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G.
BMC Med Genet. 2018 Sep 4;19(1):158. doi: 10.1186/s12881-018-0672-z.
8
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Mol Cancer. 2018 Feb 19;17(1):37. doi: 10.1186/s12943-018-0803-3.
9
Germline variants are enriched in -wildtype Bannayan-Riley-Ruvalcaba syndrome.
NPJ Genom Med. 2017 Dec 18;2:37. doi: 10.1038/s41525-017-0039-y. eCollection 2017.
10
Feedback regulation of RTK signaling in development.
Dev Biol. 2019 Mar 1;447(1):71-89. doi: 10.1016/j.ydbio.2017.10.017. Epub 2017 Oct 26.
Zotero 插件